It does not contain GLP-1 or synthetic GLP-1, is not a GLP-1 agonist, and makes no claims related to GLP-1 medications
J Ethnopharmacol 97:273280 Ohashi A, Yasuda H, Kamiya T, Hara H, Adachi T (2017) CAPE increases the expression of SOD3 through epigenetics in human retinal endothelial cells
Consider this scenario: a patient starts compounded semaglutide, loses weight steadily for several months, then plateaus
A microdose of GLP-1 (glucagon-like peptide-1) is an informal, non-standard term referring to the administration of GLP-1 receptor agonist medications at doses substantially lower than those licensed and recommended by UK regulatory authorities such as the MHRA (Medicines and Healthcare products Regulatory Agency) and NICE (National Institute for Health and Care Excellence)
The proposed logic is that glutathione acts as a cellular antioxidant reducing oxidative stress, while the GLP-1 medication drives weight loss and metabolic improvement, and that lowering systemic inflammation might amplify the metabolic result
Lives could be saved - Sanderspublished at 15:20 BST 24 September 2024 Lives could be saved if these drugs were more affordable, Sanders says